San Francisco,4 October 2018: According
to a report published by Grand View Research, Inc.; the global exosomes
market is anticipated to reach around USD 2.28 billion by 2030. Increasing
number of research grants and projects by numerous research organizations is
anticipated to propel the global market. Rising funding to conduct research
activities is expected to further boost the market over the forecast period
(2014 to 2030). In addition, involvement of exosomes in various functions and availability
of a variety of pathways are projected to support research activities to generate
revenue.
Nanovesicles play an important
role in intercellular communication. This is expected to increase Research and
Development (R&D) activities, thereby driving revenue growth in the coming
years. Application of vesicles as carriers of many functional contents
including proteins, lipids, and circulating nucleic acids is also likely to
support market growth. In addition, crucial applications in diagnosis and
treatment of various diseases is likely to increase adoption in research area. These
vesicles also play crucial role in tumor pathogenesis and immunosurveillance.
Rising research activities to
find the role of exosomes in Hepatocellular Carcinoma (HCC) is expected to
boost the market over the forecast period. Moreover, technological advancements
and new platforms can further support market expansion over the projected
period. New platforms will allow to find low abundant membrane proteins and this
finding can be carried out in background of complex plasma proteins. This
factor is anticipated to bode well for the overall market growth in near
future.
Access
Research Report of Exosomes
Market@ www.grandviewresearch.com/industry-analysis/exosomes-market
The worldwide exosomes market
can be segmented on the basis of workflow, biomolecule type, application, and
region. As per workflow, the market can be classified into downstream analysis
and isolation methods. Downstream analysis is anticipated to dominate the
market by 2030 due to increasing requirement for advanced technologies and
instrumentation for downstream processing.
Based on biomolecule type, the
market for exosomes can be split into non-coding RNAs, mRNA, proteins
/peptides, DNA fragments, and Lipids. Non-coding RNA is expected to capture a significant
market share in near future due to rising applications in research. In
addition, implementation of specific protocols for research in non-coding RNA
and prediction of its secondary structure is expected to boost segment growth
over the forecast period. DNA fragment is expected to grow at a substantial
pace over the forecast period on account of its application of pre-clinical
animal models.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/biotechnology
On the basis of application,
the exosomes market can be divided into neurodegenerative diseases, cancer,
cardiovascular diseases, infectious diseases, and others. Cancer dominated the application
segment in terms of market share 2016. Growing penetration of organizations in
oncology-based research on biomarker identification is anticipated to drive
growth in years to come. Exosomes are extensively used in non-invasive
biomarkers. Neurodegenerative disorder is expected to showcase significant
growth in the forthcoming years due to increased research regarding the use of these
vesicles as a therapeutic tools for brain ailments and as disease biomarker.
Geographically, the market can
be divided into North America, Asia Pacific, Europe, Latin America, and Middle
East and Africa (MEA).
In 2016, North America held
the largest revenue share. Existence of several government and private
organizations involved in development of new technologies and a steady rise in funding
for R&D activities in the U.S. are the major regional drivers. In 2017,
researchers at the Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center
acknowledged two grants from the Sohn Conference Foundation to conduct R&D
in characterization and isolation of tumor-derived exosomes to examine occurrence
of cancer in children.
Asia Pacific is expected to be
the fastest growing region over the forecast period due to enormous potential recognized
in developing countries like India and China. Increasing government backing and
competitive tactics implemented by the organizations to conduct R&D may
bode well for the regional market growth over the forecast period.
Key companies operating in the
exosomes market include Thermo Fisher Scientific, Inc.; Illumina, Inc.; Takara
Bio Company; Miltenyi Biotec; and Qiagen. Market participants are focusing on setting
up production facilities to develop particular exosomes cell lines to gain larger
market share. Companies are competing with each other on the basis of patent
filling and innovation in terms of product development. The market is expected
to witness participation of numerous new entrants in near future.
Access
Press Release of Exosomes Market@ www.grandviewresearch.com/press-release/global-exosomes-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business decisions,
we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
